THE EFFICACY OF PEMETREXED-BASED TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC), AS CORRELATED WITH THE PATHOLOGIC FEATURES OF TUMORS

被引：0
|
作者：
Shiran, I. [1 ]
Borshteen, R. [1 ]
Urban, D. [1 ]
Onn, A. [1 ]
Biran, H. [1 ]
Bar, J. [1 ]
机构：
[1] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Pemetrexed in Advanced Non-Small Cell Lung Carcinoma
    Lee, Gyu Jin
    Jung, Mann Hong
    Jang, Tae Won
    Ok, Chul Ho
    Jung, Hyun Joo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 67 (02) : 121 - 126
  • [22] Incorporation of pemetrexed (alimta) into the treatment of non-small cell lung cancer (thoracic tumors)
    Bunn, PA
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 17 - 22
  • [23] TOLERANCE AND EFFICACY OF CHEMOTHERAPY WITH PLATINUM AND PEMETREXED IN ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Leprieur, Etienne Giroux
    Labrune, Sylvie
    Giraud, Violaine
    Gendry, Thierry
    Cobarzan, Daniel
    Chinet, Thierry
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1285 - S1286
  • [24] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Effect of race on the safety and efficacy of pemetrexed (P) therapy in locally advanced and metastatic non-small cell lung cancer (NSCLC)
    Tai, D. F.
    Kulkarni, P.
    Wang, Y.
    Gill, J.
    Obasaju, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
    Greenhalgh, J.
    McLeod, C.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    Dundar, Y.
    Oyee, J.
    Dickson, R.
    Davis, H.
    Green, J.
    McKenna, E.
    Pearson, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 33 - 39
  • [27] Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)
    Schmid-Bindert, Gerald
    TARGETED ONCOLOGY, 2013, 8 (01) : 15 - 26
  • [28] Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)
    Gerald Schmid-Bindert
    Targeted Oncology, 2013, 8 : 15 - 26
  • [29] Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Tsiara, Anna
    Liontos, Michalis
    Kaparelou, Maria
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [30] Clinical Efficacy of Bevacizumab Concomitant with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer
    Zhang, Yu-Mei
    Li, Yong-Qiang
    Liu, Zhi-Hui
    Liao, Xiao-Li
    Liang, Rong
    Lin, Yan
    Yuan, Chun-Ling
    Liao, Si-Na
    Liang, Chao-Yong
    Li, Qian
    Li, Le-Qun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3447 - 3450
12345